top of page

Evidence-Based Foundations:
The Science Behind Our CBT-I Protocol

Preliminary Clinical Outcomes from a Cohort of 75 Patients

49 Patients who Completed CBT-I


Total sleep time (TST) increased by 40 minutes from pretreatment (M=380 minutes, SD=87 minutes) to posttreatment (M=420 minutes, SD=81 minutes). This difference between pre-and-post- assessment TST was statistically significant (t(48) = -3.41, p < 0.001).

Sleep onset latency (SOL) decreased pretreatment (M=48 minutes, SD=43 minutes) to posttreatment (M=18 minutes, SD=18 minutes), which resulted in a significant difference between baseline and posttreatment (t(48) = 5.59, p < 0.001).


Wake after sleep onset [WASO] decreased from pretreatment (M=61 minutes, SD=44 minutes) to posttreatment (M=24 minutes, SD=23 minutes), a difference that was statistically significant (t(48) = 5.81, p < 0.001).


Sleep efficiency (SE) percent increased from baseline (M=72%, SD=16%) to posttreatment (M=87%, SD=8%). This increase in percent sleep efficiency was statistically significant (t(48) = -6.60, p <0.001).


26 Patients who Completed CBT-I alongside Sleep Medication Tapering


70% of sleep medication tapering patients were completely tapered off of their original dose


100% of patients were down to at least half of their original dose.

81% of patients were down to the last quarter of their original dose.

For patients:

For clinicians:

bottom of page